(Q36953320)

17 August 2017

5 references

24 March 2019

22 April 2019

4 November 2019

28 November 2019

17 December 2019

What is new in iron overload? (English)

1 reference

17 August 2017

5 references

24 March 2019

22 April 2019

4 November 2019

28 November 2019

17 December 2019

1 reference

4 November 2019

1 reference

28 November 2019

1 reference

17 December 2019

Christiane Vermylen

1

1 reference

17 August 2017

26 September 2007

1 reference

PMC publication ID

2254659

European Journal of Pediatrics

17 August 2017

1 April 2008

5 references

24 March 2019

22 April 2019

4 November 2019

28 November 2019

17 December 2019

6 references

17 August 2017

24 March 2019

22 April 2019

4 November 2019

28 November 2019

17 December 2019

167

1 reference

17 August 2017

4

1 reference

17 August 2017

377-381

1 reference

Magnetic resonance imaging measurement of iron overload

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254659

Cost effectiveness of once-daily oral chelation therapy with deferasirox versus infusional deferoxamine in transfusion-dependent thalassaemia patients: US healthcare system perspective.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254659

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254659

New advances in iron chelation therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254659

Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254659

A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254659

Monitoring long-term efficacy of iron chelation treatment with biomagnetic liver susceptometry

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254659

Intracellular labile iron pools as direct targets of iron chelators: a fluorescence study of chelator action in living cells

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254659

Iron-chelating therapy with the new oral agent ICL670 (Exjade).

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254659

Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254659

New chelation therapies and emerging chelating drugs for the treatment of iron overload

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254659

Iron chelation treatment with combined therapy with deferiprone and deferioxamine: a 12-month trial

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2254659

Liver iron is a surrogate marker of severe fibrosis in chronic hepatitis C

4 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17899187

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00431-007-0604-Y

1 reference

17 August 2017

1 reference

PMC publication ID

2254659

17 August 2017

PubMed publication ID

17899187

1 reference

PMC publication ID

2254659